{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T09:02:45Z","timestamp":1780822965215,"version":"3.54.1"},"reference-count":31,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1620\/tjem.243.77","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T22:21:19Z","timestamp":1506637279000},"page":"77-83","source":"Crossref","is-referenced-by-count":18,"title":["Elevated Serum Anti-GM-CSF Antibodies before the Onset of Autoimmune Pulmonary Alveolar Proteinosis in a Patient with Sarcoidosis and Systemic Sclerosis"],"prefix":"10.1620","volume":"243","author":[{"given":"Mari","family":"Yamasue","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Nureki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Usagawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Kan","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Kadota","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","unstructured":"Akasaka, K., Tanaka, T., Kitamura, N., Ohkouchi, S., Tazawa, R., Takada, T., Ichiwata, T., Yamaguchi, E., Hirose, M., Arai, T., Nakano, K., Nei, T., Ishii, H., Handa, T., Inoue, Y. &amp; Nakata, Y. (2015) Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study. <i>BMC Pulm. Med.<\/i>, 15, 88."},{"key":"2","unstructured":"American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) (1999) Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. <i>Am. J. Respir. Crit. Care Med.<\/i>, 160, 736-755."},{"key":"3","unstructured":"Boerner, E.B., Costabel, U., Wessendorf, T.E., Theegarten, D., Hetzel, M., Drent, M. &amp; Bonella, F. (2016) Pulmonary alveolar proteinosis: another autoimmune disease associated with sarcoidosis? <i>Sarcoidosis Vasc. Diffuse Lung Dis.<\/i>, 33, 90-94."},{"key":"4","unstructured":"Bonella, F., Ohshimo, S., Miaotian, C., Griese, M., Guzman, J. &amp; Costabel, U. (2013) Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis. <i>Orphanet J. Rare Dis.<\/i>, 8, 53."},{"key":"5","unstructured":"Borie, R., Debray, M.P., Laine, C., Aubier, M. &amp; Crestani, B. (2009) Rituximab therapy in autoimmune pulmonary alveolar proteinosis. <i>Eur. Respir. J.<\/i>, 33, 1503-1506."},{"key":"6","unstructured":"Campo, I., Luisetti, M., Griese, M., Trapnell, B.C., Bonella, F., Grutters, J., Nakata, K., Van Moorsel, C.H., Costabel, U., Cottin, V., Ichiwata, T., Inoue, Y., Braschi, A., Bonizzoni, G., Iotti, G.A., et al. (2016) Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures. <i>Orphanet J. Rare Dis.<\/i>, 11, 115."},{"key":"7","unstructured":"Carey, B. &amp; Trapnell, B.C. (2010) The molecular basis of pulmonary alveolar proteinosis. <i>Clin. Immunol.<\/i>, 135, 223-235."},{"key":"8","doi-asserted-by":"crossref","unstructured":"Imura, Y., Yukawa, N., Handa, T., Nakashima, R., Murakami, K., Yoshifuji, H., Ohmura, K., Ishii, H., Nakata, K. &amp; Mimori, T. (2016) Two cases of autoimmune and secondary pulmonary alveolar proteinosis during immunosuppressive therapy in dermatomyositis with interstitial lung disease. <i>Mod. Rheumatol.<\/i>, doi.org\/10.3109\/14397595.2016.1153443 [Epub ahead of print].","DOI":"10.3109\/14397595.2016.1153443"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Inoue, Y., Nakata, K., Arai, T., Tazawa, R., Hamano, E., Nukiwa, T., Kudo, K., Keicho, N., Hizawa, N., Yamaguchi, E., Eda, R., Oishi, K., Maeda, Y., Koreeda, Y., Kodo, N. &amp; Sakatani, M. (2006) Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan. <i>Respirology<\/i>, 11, Suppl S55-60.","DOI":"10.1111\/j.1440-1843.2006.00810.x"},{"key":"10","unstructured":"Inoue, Y., Trapnell, B.C., Tazawa, R., Arai, T., Takada, T., Hizawa, N., Kasahara, Y., Tatsumi, K., Hojo, M., Ichiwata, T., Tanaka, N., Yamaguchi, E., Eda, R., Oishi, K., Tsuchihashi, Y., et al. (2008) Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. <i>Am. J. Respir. Crit. Care Med.<\/i>, 177, 752-762."},{"key":"11","doi-asserted-by":"crossref","unstructured":"Ishii, H., Trapnell, B.C., Tazawa, R., Inoue, Y., Akira, M., Kogure, Y., Tomii, K., Takada, T., Hojo, M., Ichiwata, T., Goto, H. &amp; Nakata, K. (2009) Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis. <i>Chest<\/i>, 136, 1348-1355.","DOI":"10.1378\/chest.09-0097"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Khan, A., Agarwal, R. &amp; Aggarwal, A.N. (2012) Effectiveness of granulocyte-macrophage colony-stimulating factor therapy in autoimmune pulmonary alveolar proteinosis: a meta-analysis of observational studies. <i>Chest<\/i>, 141, 1273-1283.","DOI":"10.1378\/chest.11-0951"},{"key":"13","unstructured":"Kinehara, Y., Kida, H., Inoue, Y., Hirose, M., Nakabayashi, A., Takeuchi, Y., Hayama, Y., Fukushima, K., Hirata, H., Inoue, K., Minami, T., Nagatomo, I., Takeda, Y., Funakoshi, T., Kijima, T. &amp; Kumanogoh, A. (2014) Development of microscopic polyangiitis-related pulmonary fibrosis in a patient with autoimmune pulmonary alveolar proteinosis. <i>BMC Pulm. Med.<\/i>, 14, 172."},{"key":"14","unstructured":"Kitamura, T., Tanaka, N., Watanabe, J., Uchida, Kanegasaki, S., Yamada, Y. &amp; Nakata, K. (1999) Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte\/macrophage colony-stimulating factor. <i>J. Exp. Med.<\/i>, 190, 875-880."},{"key":"15","unstructured":"Kitamura, T., Uchida, K., Tanaka, N., Tsuchiya, T., Watanabe, J., Yamada, Y., Hanaoka, K., Seymour, J.F., Schoch, O.D., Doyle, I., Inoue, Y., Sakatani, M., Kudoh, S., Azuma, A., Nukiwa, T., et al. (2000) Serological diagnosis of idiopathic pulmonary alveolar proteinosis. <i>Am. J. Respir. Crit. Care Med.<\/i>, 162, 658-662."},{"key":"16","doi-asserted-by":"crossref","unstructured":"Kohno, N., Kyoizumi, S., Awaya, Y., Fukuhara, H., Yamakido, M. &amp; Akiyama, M. (1989) New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. <i>Chest<\/i>, 96, 68-73.","DOI":"10.1378\/chest.96.1.68"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Lin, F.C., Chen, Y.C. &amp; Chang, S.C. (2008) Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis. <i>Mayo Clin. Proc.<\/i>, 83, 1344-1349.","DOI":"10.4065\/83.12.1344"},{"key":"18","unstructured":"Luisetti, M., Rodi, G., Perotti, C., Campo, I., Mariani, F., Pozzi, E. &amp; Trapnell, B.C. (2009) Plasmapheresis for treatment of pulmonary alveolar proteinosis. <i>Eur. Respir. J.<\/i>, 33, 1220-1222."},{"key":"19","doi-asserted-by":"crossref","unstructured":"Nagasawa, J., Kurasawa, K., Maezawa, R., Owada, T., Hanaoka, R. &amp; Fukuda, T. (2013) Systemic lupus erythematosus complicating autoimmune pulmonary alveolar proteinosis that was worsened by immunosuppressive therapy. <i>Lupus<\/i>, 22, 1060-1063.","DOI":"10.1177\/0961203313498798"},{"key":"20","unstructured":"Nara, M., Sano, K., Ogawa, H., Tamada, T., Nagaoka, M., Okada, K., Watanabe, M., Moriya, T., Miki, H., Nakata, K., Ichinose, M. &amp; Hattori, T. (2006) Serum antibody against granulocyte\/macrophage colony-stimulating factor and KL-6 in idiopathic pulmonary alveolar proteinosis. <i>Tohoku J. Exp. Med.<\/i>, 208, 349-354."},{"key":"21","unstructured":"Oltmanns, U., Schmidt, B., Hoernig, S., Witt, C. &amp; John, M. (2003) Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis. <i>Exp. Lung Res.<\/i>, 29, 315-328."},{"key":"22","doi-asserted-by":"crossref","unstructured":"Schoch, O.D., Schanz, U., Koller, M., Nakata, K., Seymour, J.F., Russi, E.W. &amp; Boehler, A. (2002) BAL findings in a patient with pulmonary alveolar proteinosis successfully treated with GM-CSF. <i>Thorax<\/i>, 57, 277-280.","DOI":"10.1136\/thorax.57.3.277"},{"key":"23","unstructured":"Seymour, J.F. &amp; Presneill, J.J. (2002) Pulmonary alveolar proteinosis: progress in the first 44 years. <i>Am. J. Respir. Crit. Care Med.<\/i>, 166, 215-235."},{"key":"24","unstructured":"Tazawa, R., Trapnell, B.C., Inoue, Y., Arai, T., Takada, T., Nasuhara, Y., Hizawa, N., Kasahara, Y., Tatsumi, K., Hojo, M., Ishii, H., Yokoba, M., Tanaka, N., Yamaguchi, E., Eda, R., et al. (2010) Inhaled granulocyte\/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. <i>Am. J. Respir. Crit. Care Med.<\/i>, 181, 1345-1354."},{"key":"25","unstructured":"Torok, K.S., Kurzinski, K., Kelsey, C., Yabes, J., Magee, K., Vallejo, A.N., Medsger, T. Jr. &amp; Feghali-Bostwick, C.A. (2015) Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles. <i>Semin. Arthritis Rheum.<\/i>, 45, 284-293."},{"key":"26","unstructured":"Trapnell, B.C., Whitsett, J.A. &amp; Nakata, K. (2003) Pulmonary alveolar proteinosis. <i>N. Engl. J. Med.<\/i>, 349, 2527-2539."},{"key":"27","unstructured":"Uchida, K., Beck, D.C., Yamamoto, T., Berclaz, P.Y., Abe, S., Staudt, M.K., Carey, B.C., Filippi, M.D., Wert, S.E., Denson, L.A., Puchalski, J.T., Hauck, D.M. &amp; Trapnell, B.C. (2007) GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. <i>N. Engl. J. Med.<\/i>, 356, 567-579."},{"key":"28","unstructured":"Uchida, K., Nakata, K., Carey, B., Chalk, C., Suzuki, T., Sakagami, T., Koch, D.E., Stevens, C., Inoue, Y., Yamada, Y. &amp; Trapnell, B.C. (2014) Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis. <i>J. Immunol. Methods<\/i>, 402, 57-70."},{"key":"29","doi-asserted-by":"crossref","unstructured":"Uchida, K., Nakata, K., Suzuki, T., Luisetti, M., Watanabe, M., Koch, D.E., Stevens, C.A., Beck, D.C., Denson, L.A., Carey, B.C., Keicho, N., Krischer, J.P., Yamada, Y. &amp; Trapnell, B.C. (2009) Granulocyte\/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. <i>Blood<\/i>, 113, 2547-2556.","DOI":"10.1182\/blood-2008-05-155689"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Uchida, K., Nakata, K., Trapnell, B.C., Terakawa, T., Hamano, E., Mikami, A., Matsushita, I., Seymour, J.F., Oh-Eda, M., Ishige, I., Eishi, Y., Kitamura, T., Yamada, Y., Hanaoka, K. &amp; Keicho, N. (2004) High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. <i>Blood<\/i>, 103, 1089-1098.","DOI":"10.1182\/blood-2003-05-1565"},{"key":"31","doi-asserted-by":"crossref","unstructured":"van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S.R., Baron, M., Tyndall, A., Matucci-Cerinic, M., Naden, R.P., Medsger, T.A. Jr., Carreira, P.E., Riemekasten, G., Clements, P.J., Denton, C.P., Distler, O., Allanore, Y., et al. (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. <i>Ann. Rheum. Dis.<\/i>, 72, 1747-1755.","DOI":"10.1136\/annrheumdis-2013-204424"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/243\/1\/243_77\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T02:24:05Z","timestamp":1570155845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/243\/1\/243_77\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.243.77","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}